The global kyphoplasty market size was valued at USD 744 million in 2025 and is projected to grow from USD 783.28 million in 2026 to USD 1182.19 million by 2034, registering a CAGR of 5.28% during the forecast period from 2026 to 2034. North America dominated the kyphoplasty market with a market share of 42.5% in 2025.
Kyphoplasty is a form of Vertebral Augmentation used to treat Compression Fractures. This surgical procedure is used to alleviate the pain caused by a spinal fracture, stabilize the bone, and restore the height of the vertebral body that was lost due to the compression fracture. In vertebroplasty, bone cement, also known as polymethyl-methacrylate, is injected into the fractured bone through a hollow needle. Before filling the space with bone cement, a balloon is inserted and inflated to restore the compressed vertebra to its normal height during kyphoplasty. Kyphoplasty is a modern spine surgical procedure for stabilizing vertebral compression fractures caused by osteoporosis, cancer, and other conditions.
Download a Free Sample To learn more about this report,
Minimally Invasive Treatment Supports Kyphoplasty Adoption
The kyphoplasty market is benefiting from continued interest in minimally invasive treatment options for vertebral compression fractures. Kyphoplasty uses a balloon to help restore the shape of a collapsed vertebra before bone cement is placed to stabilise the fracture. The approach can help address pain and spinal deformity while avoiding the larger incisions associated with conventional spinal surgery. It is used for fractures linked to conditions such as osteoporosis, cancer, and other vertebral lesions.
Advanced Balloon and Cement Delivery Technologies Improve Procedural Control
The kyphoplasty market is also moving toward technologies that give physicians greater control during vertebral fracture treatment. Manufacturers are improving balloon systems, access instruments, bone cements, and delivery devices to support more controlled fracture reduction and cement placement. These developments are particularly relevant as physicians treat different vertebral anatomies and seek predictable procedural performance. Continued product development is helping expand the range of tools available for minimally invasive vertebral augmentation.
In March 2026, Medtronic highlighted its KyphoFlex balloon kit as part of its vertebral augmentation portfolio, combining steerable access and balloon technologies to support targeted cavity creation during kyphoplasty procedures. The development reflects continued efforts to give physicians greater control during minimally invasive treatment of vertebral compression fractures.
Rising Prevalence of Osteoporosis and Vertebral Compression Fractures
The kyphoplasty market is being driven by the growing burden of osteoporosis and vertebral compression fractures, particularly among older adults. Osteoporosis weakens bones and can cause fractures following minor falls or normal physical activity, with the spine being one of the most commonly affected areas. As the aging population expands, the need for effective treatment of painful vertebral fractures is increasing. This is strengthening kyphoplasty market demand and influencing kyphoplasty market trends toward minimally invasive procedures that can stabilize fractured vertebrae and help restore mobility. Current clinical guidance recognizes kyphoplasty as an option for selected patients whose symptoms persist despite conservative treatment.
In January 2026, the American Academy of Family Physicians highlighted that vertebral compression fractures are the most common complication of osteoporosis and reported approximately 1.4 million cases worldwide. The clinical guidance noted that kyphoplasty may be considered for symptomatic fractures when patients do not respond adequately to conservative treatment, supporting continued demand for minimally invasive spinal fracture management.
Limited Patient Eligibility and Dependence on Conservative Treatment
The market faces restraints because kyphoplasty is not appropriate for every patient with a vertebral compression fracture. Treatment decisions depend on factors such as fracture severity, neurological status, imaging findings, pain intensity, fracture stability, and response to nonsurgical management. Many patients are initially treated with pain medication, rehabilitation, physical therapy, or bracing before an invasive procedure is considered. These clinical requirements create kyphoplasty industry challenges and can influence kyphoplasty market development by limiting the number of patients who are immediately eligible for vertebral augmentation.
In January 2025, the Centers for Medicare & Medicaid Services coverage guidance specified clinical requirements for percutaneous vertebral augmentation in osteoporotic vertebral compression fractures, including documented imaging evidence, significant symptoms, and inadequate response to appropriate nonsurgical management. The criteria demonstrate the importance of careful patient selection before kyphoplasty is performed.
Development of Advanced Vertebral Augmentation Technologies
The market presents significant opportunities through the development of improved balloon systems, bone cements, delivery devices, imaging technologies, and mechanical vertebral augmentation systems. Innovations designed to improve cement control, restore vertebral body height, reduce procedural complexity, and enhance treatment precision can expand options for patients with painful spinal fractures. The continued development of minimally invasive technologies is creating new kyphoplasty market opportunities and supporting kyphoplasty market growth as healthcare providers seek procedures that can improve patient mobility and reduce the burden associated with vertebral fractures.
In June 2026, RadiologyInfo updated its patient guidance on vertebroplasty and kyphoplasty, describing kyphoplasty as a procedure in which a balloon is inserted into a fractured vertebra to create a space before bone cement is introduced. The continued clinical use and education surrounding balloon-assisted vertebral augmentation demonstrate ongoing opportunities for minimally invasive treatment technologies.
Managing Procedural Risks and Establishing Consistent Long-Term Outcomes
The kyphoplasty market continues to face challenges associated with procedural complications, patient selection, cement leakage, infection, neurological injury, and the possibility of additional vertebral fractures. Healthcare professionals must balance potential pain relief and functional improvement against the risks associated with vertebral augmentation. Clinical evidence has also produced varying conclusions regarding the comparative effectiveness of different augmentation approaches, creating a need for further high-quality research. These considerations are shaping the kyphoplasty market outlook and encouraging manufacturers and healthcare providers to improve procedural safety, imaging guidance, bone cement delivery, and clinical evidence.
In September 2022, the World Federation of Neurosurgical Societies Spine Committee published recommendations on vertebral augmentation for osteoporotic spinal fractures. The committee noted that evidence regarding the effectiveness of vertebral augmentation compared with placebo remained conflicting and emphasized the need for additional high-quality randomized studies, highlighting the continuing challenge of establishing consistent clinical evidence for these procedures.
Balloon Catheters Segment Dominated the Kyphoplasty Market with 27.8% Share in 2025
The balloon catheters segment dominated the global kyphoplasty market with a 27.8% share in 2025, driven by the important role of balloon catheters in restoring vertebral height and creating a cavity within fractured vertebrae before bone cement is introduced. Their use supports controlled procedures for vertebral compression fractures and helps physicians achieve more precise treatment outcomes. Growing demand for minimally invasive spinal procedures and increasing prevalence of vertebral fractures are supporting the adoption of balloon catheter systems.
Bone access devices continue to play an important role in providing controlled access to the affected vertebra during kyphoplasty procedures. Cement application products support the precise delivery of bone cement, while bone cement provides structural stabilization following vertebral fracture treatment. Cement mixing systems help prepare cement with consistent characteristics, while specialised instruments support physicians throughout different stages of the procedure.
Request Customizationto receive a tailored report.
Vertebral Alignment Restoration Segment is Projected to Register the Fastest Growth in the Kyphoplasty Market at a CAGR of 6.4%
The vertebral alignment restoration segment is projected to register the fastest growth in the global kyphoplasty market at a CAGR of 6.4% during 2026–2034, driven by increasing demand for minimally invasive procedures that can help restore vertebral height and improve spinal alignment following compression fractures. Kyphoplasty can help reduce pain while addressing structural changes associated with vertebral collapse. Growing awareness of minimally invasive spinal interventions and increasing incidence of vertebral fractures are supporting the expansion of this application.
Spinal fractures remain a major application for kyphoplasty as healthcare providers seek minimally invasive approaches for stabilizing fractured vertebrae and managing associated pain. Kyphosis applications continue to benefit from procedures designed to address vertebral deformity and improve spinal alignment, particularly when vertebral compression contributes to changes in posture.
Osteoporosis Segment Dominated the Kyphoplasty Market with 76.9% Share in 2025
The osteoporosis segment dominated the global kyphoplasty market with a 76.9% share in 2025, driven by the strong association between osteoporosis and vertebral compression fractures. Reduced bone density can increase the risk of vertebral fractures, particularly among older adults, creating demand for procedures that can stabilize affected vertebrae and help manage fracture-related pain. Increasing awareness of osteoporosis, an aging population, and growing demand for minimally invasive fracture treatment are supporting the use of kyphoplasty in osteoporosis-related cases.
Other indications continue to contribute to the market as kyphoplasty is used in selected cases involving vertebral compression and structural spinal damage. Advances in minimally invasive techniques and improvements in procedural equipment are supporting the use of kyphoplasty across a broader range of appropriate clinical conditions.
Ambulatory Surgical Centers Segment is Projected to Register the Fastest Growth in the Kyphoplasty Market at a CAGR of 6.8%
The ambulatory surgical centers segment is projected to register the fastest growth in the global kyphoplasty market at a CAGR of 6.8% during 2026–2034, driven by the increasing shift toward minimally invasive procedures in outpatient and short-stay healthcare settings. Ambulatory surgical centers can provide efficient procedural environments, shorter hospital stays, and potentially lower treatment costs for suitable patients. Growing adoption of outpatient spinal procedures and improvements in minimally invasive surgical techniques are supporting the expansion of kyphoplasty in these facilities.
Hospitals and clinics remain an important end-use setting because they provide comprehensive infrastructure, specialist expertise, diagnostic capabilities, and post-procedure care for patients undergoing kyphoplasty. These facilities continue to manage complex spinal conditions and provide access to multidisciplinary care when required.
Speak to an Analystto discuss market opportunities.
North America accounted for the largest share of the global kyphoplasty market, representing 42.5% of total revenue and reaching USD 0.32 billion in 2025. The region is projected to grow at a CAGR of 5.8% during 2026–2034. Rising incidence of vertebral compression fractures, an aging population, increasing demand for minimally invasive spinal procedures, and improvements in image-guided surgical technologies are supporting regional market growth. Greater awareness of procedures that can provide pain relief and improve mobility is also contributing to adoption.
The US market was valued at approximately USD 0.27 billion in 2025, making it the largest contributor in North America. A large aging population, increasing prevalence of osteoporosis-related vertebral fractures, advanced healthcare infrastructure, and growing use of minimally invasive spinal procedures are supporting market development. Continued adoption of image-guided interventions is also contributing to demand.
Canada's market reached approximately USD 0.05 billion in 2025. Increasing demand for minimally invasive treatment options, an aging population, and growing awareness of vertebral fracture management are supporting market growth. Improvements in hospital infrastructure and access to advanced spinal procedures are also contributing to market development.
Unlock Regional Insightsto access country-level data, & regional trends.
Asia Pacific accounted for 19.6% of the global kyphoplasty market, valued at USD 0.15 billion in 2025, and is projected to register the fastest CAGR of 7.8% during 2026–2034. Rising healthcare expenditure, increasing elderly populations, improving hospital infrastructure, and growing awareness of minimally invasive spinal treatments are driving regional expansion. Greater access to advanced medical technologies and increasing diagnosis of osteoporosis-related fractures are further supporting demand.
Japan's market generated approximately USD 0.03 billion in 2025. A rapidly aging population, high demand for orthopedic care, and increasing focus on minimally invasive treatment approaches are supporting market development. Growing availability of advanced spinal intervention technologies is also contributing to adoption.
China accounted for a major share of the Asia Pacific market, reaching approximately USD 0.07 billion in 2025. A growing elderly population, increasing healthcare expenditure, expanding hospital infrastructure, and rising awareness of vertebral fracture treatment are supporting market growth. Improved access to minimally invasive procedures is also creating additional opportunities.
Europe accounted for 28.4% of the global kyphoplasty market, reaching USD 0.21 billion in 2025, and is projected to grow at a CAGR of 5.6% during 2026–2034. The regional market is supported by an aging population, increasing prevalence of osteoporosis, established healthcare infrastructure, and growing adoption of minimally invasive spinal procedures. Improvements in diagnostic imaging and greater awareness of vertebral compression fracture treatment are also supporting market expansion.
The UK market was valued at approximately USD 0.04 billion in 2025. Rising demand for minimally invasive spinal procedures, increasing orthopedic care needs, and greater awareness of vertebral compression fracture treatment are supporting market development. Continued investment in advanced diagnostic and surgical technologies is also contributing to adoption.
Germany's market accounted for approximately USD 0.06 billion in 2025. An aging population, established orthopedic healthcare infrastructure, and increasing demand for minimally invasive spinal interventions are supporting market growth. Growing use of advanced imaging and surgical technologies is further strengthening the market.
Latin America accounted for 5.4% of the global kyphoplasty market, reaching USD 0.04 billion in 2025, and is projected to grow at a CAGR of 6.4% during 2026–2034. Increasing healthcare investment, improving access to orthopedic services, rising awareness of minimally invasive procedures, and the growing burden of age-related bone disorders are supporting regional development. Expansion of healthcare infrastructure is also creating opportunities for advanced spinal treatments.
Brazil's market was valued at approximately USD 0.02 billion in 2025. Increasing healthcare expenditure, a growing elderly population, and improving access to orthopedic and spinal care are supporting demand for minimally invasive procedures. Greater awareness of vertebral compression fracture treatment is also contributing to market development.
Mexico's market reached approximately USD 0.01 billion in 2025. Expanding healthcare infrastructure, increasing demand for orthopedic procedures, and growing awareness of minimally invasive spinal treatments are supporting market growth. Improvements in access to advanced medical technologies are expected to create further opportunities.
Middle East & Africa accounted for 4.1% of the global kyphoplasty market, totalling USD 0.03 billion in 2025, and is projected to grow at a CAGR of 5.9% during 2026–2034. Growing healthcare investment, improving hospital infrastructure, increasing access to orthopedic care, and rising awareness of minimally invasive spinal procedures are supporting regional growth. Expanding access to advanced diagnostic and treatment technologies is also creating opportunities.
The UAE market was valued at approximately USD 0.01 billion in 2025. Increasing healthcare investment, advanced hospital infrastructure, and growing availability of minimally invasive orthopedic procedures are supporting market development. Rising demand for specialised spinal care is also contributing to adoption.
Africa's market reached approximately USD 0.02 billion in 2025. Improving healthcare infrastructure, increasing access to orthopedic services, and growing awareness of spinal fracture treatment are supporting market development. Continued investment in specialised healthcare facilities and advanced medical technologies is expected to create further opportunities.
The global kyphoplasty market is competitive, with medical device manufacturers developing balloon kyphoplasty systems, bone cement delivery technologies, access instruments, and minimally invasive spinal treatment solutions. The top players in the industry include Stryker, Medtronic Inc., Smith & Nephew, MicroPort Scientific Corporation, DePuy Synthes (Johnson & Johnson Services Inc.), IZI Medical Products, CareFusion, Merit Medical Systems, joimax GmbH, G21 S.r.l., Joline GmbH & Co. KG, Seawon MediTech, Hensler Surgical Products, Taeyeon Medical Co. Ltd., iMEDICOM, Jiangsu ChangMei Medtech Co. Ltd., and others.
Industry participants are focusing on improving the precision and safety of vertebral augmentation procedures while developing easier-to-use instruments and delivery systems. Companies are also working on minimally invasive approaches that can help physicians restore vertebral body height, stabilize fractured vertebrae, and reduce procedure-related complications. Stryker, for example, offers the AVAflex® Balloon Kyphoplasty System, designed to provide access to the vertebral body and support balloon kyphoplasty procedures for vertebral compression fractures.
Stryker: An Emerging Market Player
Stryker is a prominent participant in the kyphoplasty market, with spinal and vertebral augmentation technologies designed to support minimally invasive treatment of vertebral compression fractures. The company's portfolio includes balloon kyphoplasty products and related instruments used by physicians during vertebral augmentation procedures.
Stryker continues to develop its vertebral augmentation portfolio with a focus on procedural efficiency, controlled access, and delivery of bone cement during kyphoplasty. Its AVAflex® Balloon Kyphoplasty System incorporates a steerable access system designed to provide physicians with greater control when navigating the vertebral body, supporting accurate placement during minimally invasive procedures.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Her work focuses on assessing treatment landscapes, outsourcing models, technology adoption, market access dynamics, regulatory developments, and competitive positioning across healthcare and life sciences industries. Debashree has consistently supported organizations in understanding market gaps, evaluating revenue potential, developing market entry strategies, and shaping expansion plans across complex and fast evolving healthcare markets.
With a strong analytical foundation and structured research approach, she excels at synthesizing large datasets, stakeholder inputs, and market signals into actionable insights that guide strategic decision making. Her healthcare expertise enables her to connect clinical, commercial, and operational developments with business opportunities, helping stakeholders anticipate shifts and capitalize on emerging growth areas. Debashree’s consulting oriented mindset and deep healthcare industry understanding make her a trusted advisor to businesses navigating dynamic and rapidly evolving healthcare markets.
Assisted Walking Devices Market Size, Share, Growth, 2034
Spirometer Market Size, Share, Growth, Analysis, Report, 2034
Vessel Sealing Devices Market Size, Share, Growth, Analysis, 2034
ECG Patch and Holter Monitor Market Size, Share, Growth, 2034
Tampon Market Size, Share, Growth, Opportunities, Analysis, 2034
Artificial Cornea and Corneal Implant Market Size, Share, 2034
We are featured on:
sales@straitsresearch.com